Targeting IL-6-STAT3/STAT4 Signaling Restores FOXP3 Expression in Pulmonary Arterial Endothelium and Reveals Novel Biomarkers for PAH. The gene discussed is FOXP3; the disease is pulmonary arterial hypertension.